Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial Comparing Low Dose Tadalafil Versus Solifenacin For Management of Overactive Bladder in Women: Multicenter Egyptian National Study (WoMEN'S)

NCT07416968 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT07416968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07416968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial Comparing Low Dose Tadalafil Versus Solifenacin For Management of Overactive Bladder in Women: Multicenter Egyptian National Study (WoMEN'S)
Lead sponsor
Mansoura University
Phase
Phase 4
Overall status
Recruiting
Start date
September 1, 2025
Completion date
December 31, 2026
Enrollment
480 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder (oab), overactive bladder syndrome